Amneal Pharmaceuticals Inc. (NASDAQ: AMRX) announced that the U.S. Food and Drug Administration has approved its romidepsin injection solution, 27.5 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA